Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yu-Dian Tang
- Development stage
- Phase 1
- Lead developer
- Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Administration
- Oral
01
Overview
Yu-Dian Tang is a traditional Chinese herbal formula administered orally as a decoction. It is being investigated in a randomized controlled trial for the treatment of post-stroke depression. The herbal decoction is prepared and supplied by Heilongjiang Mental Health Hospital, with assurances that no endangered or restricted herbs are used in its composition.
Beyond the preview
Go deeper on Yu-Dian Tang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yu-Dian Tang.